Department of Large Animal Clinical Sciences, University of Florida, Gainesville, Florida, USA
D. H. Barron Reproductive and Perinatal Biology Research Program, University of Florida, Gainesville, Florida, USA.
Appl Environ Microbiol. 2020 Sep 1;86(18). doi: 10.1128/AEM.01066-20.
The objective of this study was to evaluate the effect of chitosan microparticles on the uterine microbiome of cows with metritis. Dairy cows with metritis ( = 89) were assigned to 1 of 3 treatments: chitosan microparticles ( = 21), in which the cows received an intrauterine infusion of chitosan microparticles at metritis diagnosis (day 0), day 2, and day 4; ceftiofur ( = 25), in which the cows received a subcutaneous injection of ceftiofur on day 0 and day 3; and no intrauterine or subcutaneous treatment ( = 23). Nonmetritic cows ( = 20) were healthy cows matched with cows with metritis by the number of days postpartum at metritis diagnosis. Uterine swab samples collected on days 0, 3, 6, 9, and 12 were used for 16S rRNA gene sequencing and 16S RNA gene copy number quantification by quantitative PCR. Principal-coordinate analysis showed that the microbiome of the ceftiofur-treated and metritic untreated groups progressed toward that of the nonmetritic group by day 3, whereas that of the chitosan microparticle-treated group remained unchanged. The differences on day 3 were mainly due to a greater relative abundance of , particularly , in the chitosan microparticle-treated group than in the ceftiofur-treated and metritic untreated groups. Furthermore, the microbiome of the ceftiofur-treated group became similar to that of the nonmetritic group by day 9, whereas the microbiome of the chitosan microparticle-treated and metritic untreated groups became similar to that of the nonmetritic group only by day 12. The total bacterial 16S rRNA gene counts in the chitosan microparticle-treated group were greater than those in the metritic untreated controls on days 6 and 9, whereas the ceftiofur treatment group was the only group in which the total bacterial 16S rRNA gene count became similar to that in the nonmetritic group by day 12. In summary, chitosan microparticles slowed the progression of the uterine microbiome toward a healthy state, whereas ceftiofur hastened the progression toward a healthy state. Third-generation cephalosporins, such as ceftiofur, are commonly used to treat metritis in dairy cows. Chitosan microparticles has been shown to have a broad spectrum of activity and to be effective against uterine pathogens ; therefore, they have been hailed as a possible alternative to traditional antibiotics. Nonetheless, in the present study, we saw that chitosan microparticle treatment slowed the progression of the uterine microbiome of cows with metritis toward a healthy state, whereas ceftiofur treatment hastened the progression toward a healthy state. Given the lack of an effective alternative to traditional antibiotics and an increased concern about antimicrobial resistance, a greater effort should be devoted to the prevention of metritis in dairy cows.
本研究旨在评估壳聚糖微球对患有子宫炎奶牛子宫微生物组的影响。患有子宫炎的奶牛(n=89)被分为 3 种治疗组之一:壳聚糖微球(n=21),奶牛在子宫炎诊断时(第 0 天)、第 2 天和第 4 天接受壳聚糖微球宫内灌注;头孢噻呋(n=25),奶牛在第 0 天和第 3 天接受头孢噻呋皮下注射;未进行宫内或皮下治疗(n=23)。非子宫炎奶牛(n=20)为与子宫炎奶牛相匹配的产后天数相同的健康奶牛。在第 0、3、6、9 和 12 天采集子宫拭子样本,用于 16S rRNA 基因测序和通过定量 PCR 进行 16S RNA 基因拷贝数定量。主坐标分析显示,头孢噻呋治疗组和未治疗的子宫炎组的微生物组在第 3 天向非子宫炎组的微生物组发展,而壳聚糖微球治疗组的微生物组没有变化。第 3 天的差异主要是由于壳聚糖微球治疗组中相对丰度更高的 ,特别是 ,高于头孢噻呋治疗组和未治疗的子宫炎组。此外,头孢噻呋治疗组的微生物组在第 9 天变得与非子宫炎组相似,而壳聚糖微球治疗组和未治疗的子宫炎组的微生物组仅在第 12 天变得与非子宫炎组相似。壳聚糖微球治疗组在第 6 天和第 9 天的总细菌 16S rRNA 基因计数高于未治疗的子宫炎对照组,而只有头孢噻呋治疗组的总细菌 16S rRNA 基因计数在第 12 天变得与非子宫炎组相似。总之,壳聚糖微球减缓了子宫微生物组向健康状态的发展,而头孢噻呋则加速了这一进程。第三代头孢菌素,如头孢噻呋,常用于治疗奶牛子宫炎。壳聚糖微球具有广谱活性,并对子宫病原体有效;因此,它们被誉为传统抗生素的一种可能替代品。然而,在本研究中,我们发现壳聚糖微球治疗组奶牛的子宫微生物组向健康状态的发展速度较慢,而头孢噻呋治疗组奶牛的子宫微生物组向健康状态的发展速度较快。鉴于缺乏传统抗生素的有效替代品以及对抗微生物药物耐药性的担忧日益增加,应该更加努力预防奶牛子宫炎。